HAL vs TARS · P/E 9.3, $19.05B cap vs rev $183.0M
Halliburton Company (HAL) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TARS currently screens at market cap $2.66B.
Not investment advice. Open the HAL and TARS stock pages for the full models.
Not investment advice.